Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CWK | Restricted Stock Units | Options Exercise | $0 | -6.68K | -33.33% | $0.00 | 13.4K | Feb 24, 2023 | Ordinary Shares | 6.68K | Direct | F1, F2 | |
transaction | CWK | Restricted Stock Units | Options Exercise | $0 | -19.6K | -50% | $0.00 | 19.6K | Feb 25, 2023 | Ordinary Shares | 19.6K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan. |
F2 | RSUs were granted on February 24, 2022, and vest in three (3) substantially equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date. The reporting person has elected to defer settlement of award until the earlier of January 2027 or termination under the Cushman & Wakefield plc Deferred Compensation Plan (the "Deferred Compensation Plan"). |
F3 | RSUs were granted on February 25, 2021 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date. The reporting person has elected to defer settlement of award until the earlier of January 2026 or termination under the Deferred Compensation Plan. |
Executive VP, General Counsel and Corporate Secretary